AirSeal is selected as a recipient of the first WashU Venture Network Follow-on Investments
AirSeal is selected as a recipient of the first WashU Venture Network Follow-on Investments https://www.linkedin.com/posts/arch-grants_stlmade-championthebold-2022cohort-activity- utm_source=share&utm_medium=member_desktop&rcm=ACoAAE3ILu4BTUGr_Y8qvvLgjbd2F6ZmYMFnz0
Our co-founder, Dr. Zayed, was recently interviewed by KMOX Radio
Our co-founder, Dr. Zayed, was recently interviewed by KMOX Radio discussing our innovative PADGuard blood test. During the interview, Dr. Zayed explained how this breakthrough technology will transform the diagnosis and care of patients with Peripheral Arterial Disease by enabling earlier detection and more personalized treatment plans. https://lnkd.in/eQiudG4A
AirSeal is awarded a co-investment of $500,000 from Missouri Technology Corporation (MTC)
AirSeal is awarded a co-investment of $500,000 from Missouri Technology Corporation (MTC) https://www.missouritechnology.com/2024/11/05/mtc-awards-2-55-million-in-the-october-2024-investment-cycle/
AirSeal is selected as a 2024 Arch Grants recipient, which includes a $75,000 non-dilutive cash award.
AirSeal is selected as a 2024 Arch Grants recipient, which includes a $75,000 non-dilutive cash award. https://olin.wustl.edu/about/news-and-media/news/2024/12/olin-emba-alums-arch-grants-healthcare-startups.php
AirSeal is honored to be selected as 1st first-place winner for the Biotech
AirSeal is honored to be selected as 1st first-place winner for the Biotech / Healthtech Semi-Finals in St. Louis competition of 2024 Startup World Cup. https://www.linkedin.com/posts/techstl_stlouis-biotech-healthtech-activity-7203858820966539264–X1O?utm_source=share&utm_medium=member_desktop
AirSeal CardioVascular wins the 2024 Global Impact Award from WashU Skandalaris Center
AirSeal CardioVascular wins the 2024 Global Impact Award from WashU Skandalaris Center https://skandalaris.wustl.edu/blog/2024/04/18/an-unprecedented-night-at-the-innovation-entrepreneurship-awards/ https://skandalaris.wustl.edu/sc-programs/global-impact-award/
AirSeal CardioVascular and Dr. Zayed is highlighted in St. Louis Magazine
AirSeal CardioVascular and Dr. Zayed is highlighted in St. Louis Magazine as ‘Ones to Watch: St. Louisans driving disruption in a range of industries’ and TMC blog page https://www.stlmag.com/business/st-louisans-driving-disruption-range-industries/ https://www.tmc.edu/blog/unveiling-progress-latest-developments-from-tmcis-accelerator-for-healthtech-cohort/
Richard Clark joins AirSeal as a general manager and CEO
Richard Clark joins AirSeal as a general manager and CEO. Richard is a seasoned entrepreneur with 2 previous exits and brings over 40 years of business experience in health tech and pharmaceutical industry to AirSeal. He is a member of the EXECUTIVE IN RESIDENCE program of BioGenerator. Welcome Richard! https://www.biogeneratorventures.com/team?detail=367
AirSeal is selected as one of the seven companies to be part of TMC Innovation
AirSeal is selected as one of the seven companies to be part of TMC Innovation Healthtech Accelerator Cohort 17. We are leveraging resources and advices from TMC to further collaborations and commercialization efforts https://www.tmc.edu/blog/tmc-innovation-factory-hosts-cohort-17-for-its-healthtech-accelorator-bootcamp/
AirSeal is one of the ten teams (selected from hundreds of global applicants) to attend the TMCi Healthtech Accelerator Bootcamp. We are excited to meet other venture teams and TMCi advisors. https://www.tmc.edu/blog/tmc-innovation-factory-hosts-cohort-17-for-its-healthtech-accelorator-bootcamp/
